The new rules will take effect on October 5, 2022.
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
Investigators reported, “Our results revealed significant improvements in [the] overall … scores of the ASD participants, … particularly [among] those with more severe initial symptoms.”
“Recreational marijuana legalization … resulted in decreases in obesity rates for Washington State,” researchers concluded.
Most health care professionals admitted that they felt either “uncomfortable or ambivalent” regarding their knowledge of medical cannabis.
“The utility of using isolated marijuana use as a criterion for urine drug screening appears limited in benefit but rife with inequitable potential to harm,” authors concluded.
Authors predicted, “If the remaining … states without medical cannabis legalization were to legalize cannabis, spending on conventional pharmaceutical drugs would decrease by almost 11 percent.”
“Cannabidiol should be considered as a treatment option in managing symptoms related to autism,” investigators concluded.
Subjects exhibited modest improvements following the administration of THC-dominant cannabis, but they failed to demonstrate similar improvements following the use of lower potency varieties.